Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone
Castelao, A.M.; Grinyó, J.M.; Castiñeiras, M.J.; Fiol, C.; Gilvernet, S.; Seron, D.; Torras, J.; Cruzado, J.M.; Alsina, J.
Transplantation Proceedings 27(4): 2217-2220
1995
ISSN/ISBN: 0041-1345 PMID: 7652779 Document Number: 447630
Document emailed within 1 workday
Related Documents
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285Crepaldi, G.; Baggio, G.; Arca, M.; Avellone, G.; Avogaro, P.; Bittolo Bon, G.; Bompiani, G.D.; Capurso, A.; Cattin, L.; D'Alŏ, G. 1991: Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I Archives of Internal Medicine 151(1): 146-152
Pallardo, L.M.; Sanchez, J.; Garcia, J.; Moreno, R.F.; Rochera, A.; Cabezuelo, J. 1988: Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity Transplantation Proceedings 20(5 Suppl 6: 26-27
Soonthornpun, S.; Rattarasarn, C.; Leelawattana, R.; Thamprasit, A. 1997: Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients Journal of the Medical Association of Thailand 80(1): 9-15
Jungnickel, P.W.; Cantral, K.A.; Maloley, P.A. 1992: Pravastatin: a new drug for the treatment of hypercholesterolemia Clinical Pharmacy 11(8): 677-689
Kliem, V.; Wanner, C.; Eisenhauer, T.; Olbricht, C.J.; Doll, R.; Boddaert, M.; O'Grady, P.; Krekler, M.; Mangold, B.; Christians, U. 1996: Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine Transplantation Proceedings 28(6): 3126-3128
Ferrari, P.; Weidmann, P.; Riesen, W.F.; Martius, F.; Luban, S.; Pasotti, E.; Erne, P.; Fragiacomo, C.; Noseda, G.; Reutter, F. 1993: Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study Schweizerische Medizinische Wochenschrift 123(37): 1736-1741
Bunnag, S.; Vareesangthip, K.; Ong-ajyooth, L. 2006: Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine a in renal transplantation Journal of the Medical Association of Thailand 89(Suppl 2): S228-S234
Kumar, M.S.; Samhan, M.; John, P.; al-Adnani, M.S.; Abouna, G.M. 1989: Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation? Transplantation Proceedings 21(1 Part 2): 1552-1553
Ammons, M.A.; Bauling, P.C.; Weil, R. 1986: Pneumatosis cystoides intestinalis with pneumoperitoneum in renal transplant patients on cyclosporine and prednisone Transplantation Proceedings 18(6): 1868-1870
Landsberg, D.; Rae, A.; Chiu, A.; Werb, R.; Taylor, P.; Chan-Yan, C.; Manson, A.D. 1989: The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation Transplantation Proceedings 21(2): 3323-3324
MacDonald, A.S.; Daloze, P.; Dandavino, R.; Jindal, S.; Bear, L.; Dossetor, J.B.; Klassen, J.; Stiller, C.R.; Lockwood, B.; Reeve, C.E. 1987: A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group Transplantation Proceedings 19(1 Part 3): 1865-1866
Rossini, M.; Belloni, A.; Remuzzi, G.; Perico, N. 1990: Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation Circulation 81(1): I61
Senel, M.F.; Van Buren, C.T.; Etheridge, W.B.; Barcenas, C.; Jammal, C.; Kahan, B.D. 1996: Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients Clinical Nephrology 45(1): 18-21
Sandrini, S.; Maiorca, R.; Scolari, F.; Cancarini, G.; Setti, G.; Gaggia, P.; Cristinelli, L.; Zubani, R.; Bonardelli, S.; Maffeis, R.; Portolani, N.; Nodari, F.; Giulini, S.M. 2000: A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation Transplantation 69(9): 1861-1867
Amenábar, J.J.; Gómez-Ullate, P.; García-López, F.J.; Aurrecoechea, B.; García-Erauzkin, G.; Lampreabe, I. 1998: A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation Transplantation 65(5): 653-661
Reimold, E.W. 1973: Intermittent prednisone therapy in children and adolescents after renal transplantation Pediatrics 52(2): 235-240
Craveri, A.; Citella, C.; Lanfredini, M.; Colombo, L.; Bruschi, R. 1990: Evaluation of the efficacy and safety of pravastatin in primary hypercholesterolemia Bollettino Chimico Farmaceutico 129(6): 10S-15S
Kawaguchi, H.; Komatsu, Y.; Hattori, M.; Nagata, M.; Ito, K.; Takahashi, K.; Teraoka, S.; Toma, H.; Ota, K. 1989: Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan Transplantation Proceedings 21(1 Part 2): 1698-1700
Aldrete-Velasco, J.; Casanova, J.M.; Mejía, P.; Martínez, P. 1992: Efficacy of pravastatin as a hypolipidemic agent in patients with polygenic hypercholesterolemia Archives of Medical Research 23(3): 117-122